{
  "N/R/U": null,
  "Applicant": "AstraZeneca AB",
  "BLA Number": "761104",
  "Proprietary Name": "Lumoxiti",
  "Proper Name": "moxetumomab pasudotox-tdfk",
  "BLA Type": "351(a)",
  "Strength": "1MG",
  "Dosage Form": "For Injection",
  "Route of Administration": "Intravenous",
  "Product Presentation": "Single-Dose Vial",
  "Marketing Status": "Disc",
  "Licensure": "Voluntarily Revoked",
  "Approval Date": "13-Sep-18",
  "Ref. Product Proper Name": null,
  "Ref. Product Proprietary Name": null,
  "Supplement Number": null,
  "Submission Type": "Original",
  "License Number": "2059",
  "Product Number": "1",
  "Center": "CDER",
  "Date of First Licensure": null,
  "Exclusivity Expiration Date": null,
  "First Interchangeable Exclusivity Exp. Date": null,
  "Ref. Product Exclusivity Exp. Date": null,
  "Orphan Exclusivity Exp. Date": "13-Sep-25"
}